Multivariate Logistic Regression Analysis of the Association Between Age and Fatal Outcome, by Malaria Rapid Diagnostic Test (RDT) Result, and the Effect of Malaria per Age Group (Interaction) Among 1047 Patients With Ebola Virus Disease
Variable . | Malaria RDT Negative . | Malaria RDT Positive . | Interaction . | |||
---|---|---|---|---|---|---|
Full Model, OR for Fatal Outcome (95% CI) . | P Value . | Full Model, OR for Fatal Outcome (95% CI) . | P Value . | Full Model, OR for Fatal Outcome (95% CI) . | P Value . | |
Ct of EBOV RT-PCR (increasing, continuous) | 0.7 (.7–.7) | <.001 | 0.7 (.7–.7) | <.001 | 0.7 (.7–.7) | <.001 |
Age category, y | ||||||
0–4 | 14.3 (3.5–58.5) | <.001 | 12.3 (3.2–47.7) | <.001 | 0.9 (.2–4.8)a | .86 |
5–14 | 1 (Reference) | 4.2 (1.7–10.1) | .002 | 4.2 (1.7–10.1)a | .002 | |
15–44 | 3.0 (1.5–5.9) | .002 | 2.6 (1.2–5.9) | .02 | 0.9 (.5–1.5)a | .63 |
≥45 | 5.0 (2.4–10.5) | <.001 | 3.9 (1.5–10.2) | .006 | 0.8 (.3–1.7)a | .52 |
Variable . | Malaria RDT Negative . | Malaria RDT Positive . | Interaction . | |||
---|---|---|---|---|---|---|
Full Model, OR for Fatal Outcome (95% CI) . | P Value . | Full Model, OR for Fatal Outcome (95% CI) . | P Value . | Full Model, OR for Fatal Outcome (95% CI) . | P Value . | |
Ct of EBOV RT-PCR (increasing, continuous) | 0.7 (.7–.7) | <.001 | 0.7 (.7–.7) | <.001 | 0.7 (.7–.7) | <.001 |
Age category, y | ||||||
0–4 | 14.3 (3.5–58.5) | <.001 | 12.3 (3.2–47.7) | <.001 | 0.9 (.2–4.8)a | .86 |
5–14 | 1 (Reference) | 4.2 (1.7–10.1) | .002 | 4.2 (1.7–10.1)a | .002 | |
15–44 | 3.0 (1.5–5.9) | .002 | 2.6 (1.2–5.9) | .02 | 0.9 (.5–1.5)a | .63 |
≥45 | 5.0 (2.4–10.5) | <.001 | 3.9 (1.5–10.2) | .006 | 0.8 (.3–1.7)a | .52 |
Abbreviations: CI, confidence interval; Ct, cycle threshold; EBOV, Ebola virus; OR, odds ratio; RT-PCR, reverse transcription–polymerase chain reaction.
a Estimates of the corresponding interaction terms are as follows: age 0–4 years: OR, 0.2 (95% CI, .1–1.4; P = .11); age 5–14 years: OR, 1 (reference); age 15–44 years: OR, 0.2 (95% CI, .1–.6; P = .003); and age ≥45 years: OR, 0.2 (95% CI, .1–.6; P = .006).
Multivariate Logistic Regression Analysis of the Association Between Age and Fatal Outcome, by Malaria Rapid Diagnostic Test (RDT) Result, and the Effect of Malaria per Age Group (Interaction) Among 1047 Patients With Ebola Virus Disease
Variable . | Malaria RDT Negative . | Malaria RDT Positive . | Interaction . | |||
---|---|---|---|---|---|---|
Full Model, OR for Fatal Outcome (95% CI) . | P Value . | Full Model, OR for Fatal Outcome (95% CI) . | P Value . | Full Model, OR for Fatal Outcome (95% CI) . | P Value . | |
Ct of EBOV RT-PCR (increasing, continuous) | 0.7 (.7–.7) | <.001 | 0.7 (.7–.7) | <.001 | 0.7 (.7–.7) | <.001 |
Age category, y | ||||||
0–4 | 14.3 (3.5–58.5) | <.001 | 12.3 (3.2–47.7) | <.001 | 0.9 (.2–4.8)a | .86 |
5–14 | 1 (Reference) | 4.2 (1.7–10.1) | .002 | 4.2 (1.7–10.1)a | .002 | |
15–44 | 3.0 (1.5–5.9) | .002 | 2.6 (1.2–5.9) | .02 | 0.9 (.5–1.5)a | .63 |
≥45 | 5.0 (2.4–10.5) | <.001 | 3.9 (1.5–10.2) | .006 | 0.8 (.3–1.7)a | .52 |
Variable . | Malaria RDT Negative . | Malaria RDT Positive . | Interaction . | |||
---|---|---|---|---|---|---|
Full Model, OR for Fatal Outcome (95% CI) . | P Value . | Full Model, OR for Fatal Outcome (95% CI) . | P Value . | Full Model, OR for Fatal Outcome (95% CI) . | P Value . | |
Ct of EBOV RT-PCR (increasing, continuous) | 0.7 (.7–.7) | <.001 | 0.7 (.7–.7) | <.001 | 0.7 (.7–.7) | <.001 |
Age category, y | ||||||
0–4 | 14.3 (3.5–58.5) | <.001 | 12.3 (3.2–47.7) | <.001 | 0.9 (.2–4.8)a | .86 |
5–14 | 1 (Reference) | 4.2 (1.7–10.1) | .002 | 4.2 (1.7–10.1)a | .002 | |
15–44 | 3.0 (1.5–5.9) | .002 | 2.6 (1.2–5.9) | .02 | 0.9 (.5–1.5)a | .63 |
≥45 | 5.0 (2.4–10.5) | <.001 | 3.9 (1.5–10.2) | .006 | 0.8 (.3–1.7)a | .52 |
Abbreviations: CI, confidence interval; Ct, cycle threshold; EBOV, Ebola virus; OR, odds ratio; RT-PCR, reverse transcription–polymerase chain reaction.
a Estimates of the corresponding interaction terms are as follows: age 0–4 years: OR, 0.2 (95% CI, .1–1.4; P = .11); age 5–14 years: OR, 1 (reference); age 15–44 years: OR, 0.2 (95% CI, .1–.6; P = .003); and age ≥45 years: OR, 0.2 (95% CI, .1–.6; P = .006).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.